Key Details
Price
$26.26Last Dividend
$0.43Annual ROE
2.29%Beta
0.21Events Calendar
Next earnings date:
May 01, 2025Recent quarterly earnings:
Jan 17, 2025Recent annual earnings:
Jan 17, 2025Next ex-dividend date:
N/ARecent ex-dividend date:
Jan 24, 2025Next split:
N/ARecent split:
Nov 17, 2020Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
Health experts are noticing that this winter, the number of COVID-19 cases in the U.S. is likely to be much lower than in past years. This situation may increase the pressure on Pfizer to boost its sales from treatments that are not related to COVID.
Pfizer has settled a lawsuit from a conservative organization that claimed the company's fellowship program, aimed at increasing the number of Black, Latino, and Native American leaders, unfairly discriminated against white and Asian-American applicants.
Are you looking for ways to choose powerful stocks that can outperform the market for your investment portfolio? The Zacks Style Scores can help you with that.
Instead of just focusing on Wall Street's predictions for Pfizer's (PFE) earnings, let's explore some important metrics to better understand how the company might perform in the quarter that ends in December 2024. This will give us a clearer picture of its potential.
We have just released a list of 12 Safe Stocks to Invest in for the Long Term in 2025. In this article, we will examine how Pfizer Inc. (NYSE:PFE) compares to other safe stocks for long-term investment in 2025. The US stock market is frequently seen as one of […]
Before the earnings report next Tuesday, Pfizer appears to be undervalued at its current price of $26.55 and a valuation of $150 billion. However, it might be unrealistic to expect a significant increase in value. My discounted cash flow analysis indicates the stock should be worth around $50, but this relies on the company successfully launching new products, improving operations, and reducing debt. Pfizer's management emphasizes their goals of enhancing research and development, increasing profit margins, achieving commercial success, and optimizing capital use to boost shareholder value by 2025.
When combined with reinvesting dividends, high-yield dividend stocks have shown impressive results compared to the S&P 500 over more than 20 years. Companies that consistently offer high dividend yields usually have certain important traits. AbbVie Inc. (NYSE: ABBV) is my main investment in the healthcare industry.
A Bloomberg article indicates that activist investor Starboard has decided not to nominate any directors to Pfizer's board this year, showing some leniency towards the company.
PFE's growth in the fourth quarter is probably due to its non-COVID medications and the impact of new and recently acquired products.
On Saturday, Pfizer Inc. announced the findings from the Phase 3 BREAKWATER trial. This trial looked at the effectiveness of Braftovi (encorafenib) when used together with cetuximab (known as Erbitux) and mFOLFOX6 (which includes fluorouracil, leucovorin, and oxaliplatin) in patients suffering from metastatic colorectal cancer (mCRC) with a BRAF V600E mutation.
FAQ
- What is the primary business of Pfizer?
- What is the ticker symbol for Pfizer?
- Does Pfizer pay dividends?
- What sector is Pfizer in?
- What industry is Pfizer in?
- What country is Pfizer based in?
- When did Pfizer go public?
- Is Pfizer in the S&P 500?
- Is Pfizer in the NASDAQ 100?
- Is Pfizer in the Dow Jones?
- When was Pfizer's last earnings report?
- When does Pfizer report earnings?
- Should I buy Pfizer stock now?